Anti-QS Strategies Against Pseudomonas aeruginosa Infections
Microorganisms · 07.08.2025 · 13 (8) · 1838
DOI: 10.3390/microorganisms13081838 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 07.08.2025. Verfasst von Abdelaziz Touati und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbial Ecology, Faculté des Sciences de la Nature et de la Vie (FSNV), University of Bejaia, Bejaia 06000, Algeria. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 382 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU)., Deanship of Scientific Research at Imam Mohammad Bin Saud Islamic University (IMSIU).
Abstract (Originalsprache)
Pseudomonas aeruginosa poses significant health threats due to its multidrug-resistant profile, particularly affecting immunocompromised individuals. The pathogen’s ability to produce virulence factors and antibiotic-resistant biofilms, orchestrated through quorum-sensing (QS) mechanisms, complicates conventional therapeutic interventions. This review aims to critically assess the potential of anti-QS strategies as alternatives to antibiotics against P. aeruginosa infections. Comprehensive literature searches were conducted using databases such as PubMed, Scopus, and Web of Science, focusing on studies addressing QS inhibition strategies published recently. Anti-QS strategies significantly attenuate bacterial virulence by disrupting QS-regulated genes involved in biofilm formation, motility, toxin secretion, and immune evasion. These interventions reduce the selective pressure for resistance and enhance antibiotic efficacy when used in combination therapies. Despite promising outcomes, practical application faces challenges, including specificity of inhibitors, pharmacokinetic limitations, potential cytotoxicity, and bacterial adaptability leading to resistance. Future perspectives should focus on multi-target QS inhibitors, advanced delivery systems, rigorous preclinical validations, and clinical translation frameworks. Addressing current limitations through multidisciplinary research can lead to clinically viable QS-targeted therapies, offering sustainable alternatives to traditional antibiotics and effectively managing antibiotic resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Microbial Ecology, Faculté des Sciences de la Nature et de la Vie (FSNV), University of Bejaia, Bejaia 06000, Algeria.
- Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13318, Saudi Arabia.
- Laboratory for Livestock Animal Production and Health Research, Rabie Bouchama National Veterinary School of Algiers, Issad ABBAS Street, BP 161 Oued Smar, Algiers 16059, Algeria.
ORCID-Profile: Nasir Adam Ibrahim, Takfarinas Idres
Förderung
- Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU).
- Deanship of Scientific Research at Imam Mohammad Bin Saud Islamic University (IMSIU)
Zitieren
APA
Touati, A., Ibrahim, N. A., Tighilt, L., & Idres, T. (2025). Anti-QS Strategies Against Pseudomonas aeruginosa Infections. Microorganisms, 13(8), 1838. https://doi.org/10.3390/microorganisms13081838
Vancouver
Touati A, Ibrahim NA, Tighilt L, Idres T. Anti-QS Strategies Against Pseudomonas aeruginosa Infections. Microorganisms. 2025;13(8):1838. doi:10.3390/microorganisms13081838
BibTeX
@article{Touati2025,
author = {Touati, Abdelaziz and Ibrahim, Nasir Adam and Tighilt, Lilia and Idres, Takfarinas},
title = {Anti-QS Strategies Against Pseudomonas aeruginosa Infections},
journal = {Microorganisms},
year = {2025},
volume = {13},
number = {8},
pages = {1838},
doi = {10.3390/microorganisms13081838}
}
EUVIMED